New drug combo battles tough liver cancer after other treatments fail
Disease control
Not yet recruiting
This study compares a new combination treatment (SH006 injection plus other cancer drugs) against an existing medication (regorafenib) for advanced liver cancer. It's for patients whose cancer continued to grow despite previous immunotherapy treatment. Researchers want to see if …
Phase: PHASE2, PHASE3 • Sponsor: Nanjing Sanhome Pharmaceutical, Co., Ltd. • Aim: Disease control
Last updated Apr 02, 2026 03:56 UTC